Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot tutor aims to help kids master asthma inhalers

NCT ID NCT07738016

Disease control Sponsor: University of Miami Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Sep 17, 2026 · Updated 5 times

Summary

This trial tests whether a single 10-minute lesson from an artificially intelligent robot can improve inhaler technique and asthma control in children ages 4 to 11. Researchers will compare standard asthma education with the robot-led session, measuring inhaler skills, medication adherence, and caregiver burden. The goal is to see if a friendly robot can make asthma education more engaging and effective for young patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a single 10-minute robotic asthma education session delivered by an artificially intelligent robot
What this could lead to
If it works, this could point toward a simple, engaging way to teach children proper inhaler technique and improve asthma control.
What could go wrong
This is a small, early-stage trial with only 80 participants. The robot session is brief and may not produce lasting improvements over standard education.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Caregivers or Parents: * The participant must be at least 18 years old. * The participant must be willing and able to participate. * The participant can read English or Spanish and is able to fill out survey instruments by themselves or with assistance. * The participant cares for a child age 4-11 with asthma. Inclusion Criteria for Children: * The participant must be at least 4 years old - 11 years old with asthma. * The child can speak English or Spanish. * The participant must assent to participation. * The participant's guardian must have consented. Exclusion Criteria for Caregivers or Parents: * The participant is younger than 18 years old. * The participant is unwilling to participate in the study. * The participant is unable to complete survey instruments. * The participant does not care for a child with asthma who is age 4-11. Exclusion Criteria for Children: * The participant is younger than 4 years old, over 11 years old, or does not have asthma. * The child does not speak English or Spanish. * The participant is unwilling to participate in the study. * The participant's guardian did not consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Artificial intelligence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma Caregiver Burden childhood onset asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Artificial intelligence Asthma in children Caregiver burden

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Holtz Children's Hospital

    Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.